Register for free
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vanguard U.S. Momentum Factor ETF (NY:VFMO)

186.86 +0.42 (+0.23%)
Official Closing Price Updated: 6:30 PM EDT, Sep 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,361
Open 186.86
Bid (Size) 94.06 (1)
Ask (Size) 280.74 (2)
Prev. Close 186.44
Today's Range 186.20 - 188.16
52wk Range 128.58 - 187.46
Shares Outstanding N/A
Dividend Yield 1.19%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Roivant Stock Rises After Drug Achieves Goals In Late-Stage Study: Retail Sees Further Rally To $17
Once-daily oral Brepocitinib 30 mg demonstrated clinically meaningful and statistically significant improvement compared to placebo on the primary endpoint and all key secondary endpoints in the study,... 
Via Stocktwits
Duolingo Stock Dips After Citigroup Lowers Price Target – Here’s What The Analyst Said About Duocon Event
Citigroup maintained a ‘Buy’ rating and noted that Duolingo's product announcements this year had a lower profile relative to the past. 
Via Stocktwits
Topics Artificial Intelligence

Performance

YTD
+13.1%
+13.1%
1 Month
+4.7%
+4.7%
3 Month
+13.2%
+13.2%
6 Month
+22.6%
+22.6%
1 Year
+18.8%
+18.8%

More News

Read More
Eli Lilly To Set Up $5B Facility In Virginia – More Details Inside
Via Stocktwits
Ralph Lauren Unveils Three-Year Outlook – Here Are The Key Points
Via Stocktwits
Dave & Buster’s Sees Wall Street Downgrades, Yet Retail Sentiment Red-Hot
Via Stocktwits
Caleres Draws ‘Less Risk’ Rating From Telsey, Retail Chatter Surges 700%
Via Stocktwits
Iovance Stock Rises 4% On Health Canada Approval For Cancer Immunotherapy: Retail Thinks ‘Patience Will Pay Off’
Via Stocktwits
Lyft Has A ‘Steady Path Forward’ According To UBS: Retail Thinks Stock Is Undervalued
Via Stocktwits
Ardelyx Stock Soars On Price Target Hikes After Upbeat Q2 Report: Retail Sees More Revisions Coming
Via Stocktwits
Summit Therapeutics Gets A $40 Price Target As Guggenheim Says It Likes Stock At $24, Like It Did At $3
Via Stocktwits
Agios Pharma Stock Slumped 15% Today But Company Remains Top Pick For This Analyst – Find Out More
Via Stocktwits
Zymeworks Stock Tanks Over 17% After Cancer Drug Candidate Update
Via Stocktwits
HC Wainwright Doubles Price Target On Insmed After Brinsupri Approval: Retail Expects Stock To Hit $150 By End Of Week
Via Stocktwits
Vertex Stock Sinks 12% As Pipeline Setbacks Trigger Wall Street Skepticism: But Retail Sees Opportunity
Via Stocktwits
Oscar Health Now Expects Loss From Operations Of $200M To $300M In 2025: Here’s What Retail Thinks About The Stock Price
Via Stocktwits
Hims & Hers Announces Plans To Expand Into Canada As Novo Nordisk’s Weight Loss Drug Patent Expires
Via Stocktwits
Topics Intellectual Property
Rhythm Pharma Shares Soar After Experimental Drug Yields Weight Reduction In Brain-Damage Related Obesity
Via Stocktwits
Topics Government
KalVista Stock Soars Pre-Market On FDA Approval For Drug In Treating Swelling Disorder: Retail’s Elated
Via Stocktwits
AstraZeneca In Talks To License Summit Therapeutics’ Experimental Lung Cancer Drug: Report
Via Stocktwits
5 Surprising Vanguard ETFs That Could Beat the Market
Via The Motley Fool
Topics ETFs
After Beating the S&P 500 in 2024, This Vanguard Growth ETF Is Already Up Over 6% in 2025
Via The Motley Fool
Topics ETFs Stocks
Don't Miss This Actively Managed Vanguard ETF That Could Supercharge Your Returns
Via The Motley Fool
Topics ETFs
Vanguard ETFs: An Overview
Via The Motley Fool
Topics ETFs
This Is the Perfect Vanguard ETF for Investors With a Fear of Missing Out on the Market's Biggest Winners
Via The Motley Fool
Topics ETFs
Like the "Magnificent Seven" Stocks? You'll Love This Vanguard ETF.
Via The Motley Fool
Topics ETFs

Frequently Asked Questions

Is Vanguard U.S. Momentum Factor ETF publicly traded?
Yes, Vanguard U.S. Momentum Factor ETF is publicly traded.
What exchange does Vanguard U.S. Momentum Factor ETF trade on?
Vanguard U.S. Momentum Factor ETF trades on the New York Stock Exchange
What is the ticker symbol for Vanguard U.S. Momentum Factor ETF?
The ticker symbol for Vanguard U.S. Momentum Factor ETF is VFMO on the New York Stock Exchange
What is the current price of Vanguard U.S. Momentum Factor ETF?
The current price of Vanguard U.S. Momentum Factor ETF is 186.86
When was Vanguard U.S. Momentum Factor ETF last traded?
The last trade of Vanguard U.S. Momentum Factor ETF was at 09/17/25 06:30 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS